Here's the 8-K from when he joined the board last Sept.
ADVENTRX APPOINTS JACK LIEF AS DIRECTOR
SAN DIEGO — September 22, 2006 — ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) today announced that Jack Lief, president and chief executive officer, and a founder and director, of Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), will join its board of directors. In connection with Mr. Lief’s appointment, ADVENTRX increased the size of its board from six to seven.
“Jack brings a wealth of experience and leadership within the biotechnology and pharmaceutical industries and we are delighted to welcome him to our board,” said Evan M. Levine, ADVENTRX chief executive officer. “We believe his unique perspective will be an important asset as we execute our clinical development and commercial strategies.”
“I’m very pleased to be appointed to the board of ADVENTRX,” commented Jack Lief, president and CEO of Arena. “I hope that as a member of the board I can leverage my knowledge and experience to help advance the development and commercialization of the company’s drug candidates, such as CoFactor®, which hold significant potential to provide patients with better treatment options.”
Mr. Lief is president and chief executive officer, and a founder and director, of Arena Pharmaceuticals, a clinical-stage biopharmaceutical company, since April 1997. For two years prior to founding Arena Pharmaceuticals, Mr. Lief served as a consultant to numerous biopharmaceutical organizations. From 1989 to 1994, Mr. Lief served as senior vice president, corporate development and secretary for Cephalon, Inc., a biopharmaceutical company. From 1983 to 1989, Mr. Lief served as director of business development and strategic planning for Alpha Therapeutic Corporation, a manufacturer of biological products. From 1972 until 1983, Mr. Lief worked at Abbott Laboratories, where his most recent title was head of international marketing research. Mr. Lief currently serves on several boards of directors, including Accumetrics, Inc., a developer and marketer of diagnostic tests, ReqMed Company, Ltd., a provider of partnering opportunities, R&D strategies and bio-venture funding, and TaiGen Biotechnology Co., Ltd., a biotechnology company. In addition, Mr. Lief is an executive board member for BIOCOM, a life science industry association representing more than 450 member companies in San Diego and Southern California. From March 2005 to March 2006, he served as chairman of BIOCOM. Mr. Lief earned a B.A. from Rutgers University and an M.S. in Psychology from Lehigh University. |
